Clinical Trials on Infections, Respiratory Tract in Australia

Total 4728 results

Murdoch Childrens Research Institute
Monash University; St Vincent's Hospital Melbourne; University of Melbourne; The... and other collaborators

Recruiting

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children (INHERIT)

COVID-19

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Withdrawn

COVID-19 Fourth Dose Study in Australia

COVID-19

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Active, not recruiting

COVID-19 Booster Study in Healthy Adults in Australia

COVID-19

Australia
Symvivo Corporation

Completed

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

COVID-19

Australia
Macfarlane Burnet Institute for Medical Research...

Active, not recruiting

The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)

COVID-19

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Completed

Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV). (MIACoV)

COVID-19

Australia
Telethon Kids Institute

Withdrawn

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Bronchiolitis

Australia
GlaxoSmithKline

Completed

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Neisseria Meningitidis | Haemophilus Influenzae Type b

Australia
DiaSorin Molecular LLC

Not yet recruiting

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Coronavirus Disease 2019 | Influenza A | Respiratory Syncytial Virus (RSV) | Adenovirus | Influenza Type B | Enterovirus | Mycoplasma Pneumonia | Bordetella Parapertussis Infection | Chlamydia Pneumonia | Para Influenza | Bordetella Pertussis Infection, Respiratory

Australia
The University of Queensland
Syneos Health; Coalition for Epidemic Preparedness Innovations

Completed

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Covid19 | SARS-CoV2

Australia
BeiGene

Completed

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Covid19

Australia
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
University of Melbourne
Southern Star Research Pty Ltd.

Completed

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

SARS-CoV-2

Australia
Intravacc B.V.
Novotech (Australia) Pty Limited

Completed

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers (ITV2002)

COVID-19

Australia
Seqirus

Completed

A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children

Influenza Caused by the Novel Influenza A (H1N1) Virus

Australia
Medical University of Vienna

Completed

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

Pneumonia | Urinary Tract Infection | Abdominal Infection

Austria
Osivax
Novotech (Australia) Pty Limited; Harmony Clinical Research; Northern Beaches...

Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.

Influenza

Australia
Novavax
Department of Health and Human Services

Completed

A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Influenza

Australia
Quidel Corporation

Completed

QuickVue Influenza A+B Clinical Field Trial

Influenza

Australia
Murdoch Childrens Research Institute
Bill and Melinda Gates Foundation; Royal Children's Hospital

Completed

BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)

COVID-19 | Corona Virus Infection | Coronavirus Disease 2019 (COVID-19) | Respiratory Illness

Australia, Brazil, Netherlands, Spain, United Kingdom
Seqirus

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying mRNA Influenza Vaccine in Healthy Adults

Influenza, Human

Australia
Probiomics Ltd

Unknown

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Influenza

Australia
The University of Queensland
University of California, San Diego; University of Sydney

Completed

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample)

Catastrophizing Coronavirus (COVID-19)

Australia
Ellume Pty Ltd

Completed

Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

Influenza A | Influenza B

Australia
Crucell Holland BV

Completed

Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients

Influenza

United States, Australia, Canada
The Prince Charles Hospital
Cell and Tissue Therapies Western Australia

Completed

A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation (MSC in OB)

Bronchiolitis Obliterans | Lung Transplantation

Australia
Gilead Sciences

Withdrawn

Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus Infections

Australia
Osivax
Novotech (Australia) Pty Limited; Mater Misericordiae Limited

Completed

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Influenza

Australia
Australian National University
St Vincent's Hospital Melbourne; The George Institute; Royal North Shore Hospital and other collaborators

Withdrawn

Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) (INHALE-HEP)

COVID-19

Australia
Sorrento Therapeutics, Inc.

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers

COVID-19

Australia
Murdoch Childrens Research Institute
Royal Children's Hospital

Recruiting

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children (CHOICE UTI)

Infection | Pediatric Infectious Disease | Complicated Urinary Tract Infection

Australia, New Zealand
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Pandemic H5N1 Influenza

United States, Australia, Thailand
DiaSorin Molecular LLC

Completed

LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia

Coronavirus Disease 2019 | Influenza A | Influenza Type B

Australia
Arbeitsgemeinschaft medikamentoese Tumortherapie

Unknown

Austrian COVID-19 Registry

COVID-19 | Infectious Disease

Austria
Becton, Dickinson and Company

Completed

BD Veritor™ At-Home and BD Veritor™ Professional

Upper Respiratory Infection

New Zealand, Australia, United States
Lumen Bioscience, Inc.

Completed

A Study to Determine the Tolerability of Intranasal LMN-301

COVID-19

Australia
Invivyd, Inc.
Novotech (Australia) Pty Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants

COVID-19

Australia
Vaccitech (UK) Limited
Clinical Network Services (CNS) Pty Ltd

Terminated

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

Influenza

Australia
Medical University Innsbruck

Recruiting

Neurological Outcome After SARS-CoV-2 Infection (ATTRACT)

SARS-CoV-2 | Post-acute COVID-19 Syndrome

Austria
Egalet Ltd

Completed

Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

Allergic Rhinitis

Australia
Respirion Pharmaceuticals Pty Ltd

Recruiting

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas Aeruginosa | Cystic Fibrosis Lung | Respiratory Infections, Recurrent, Chronic

United States, Australia
Western Health, Australia
Monash University; University of Melbourne; La Trobe University

Completed

IMPROVinG Outcomes in Community Acquired Pneumonia (IMPROVe-GAP)

Pneumonia

Australia
Biota Scientific Management Pty Ltd

Completed

Safety Study of Oral BTA9881 to Treat RSV Infection

Respiratory Syncytial Virus Infections

Australia
Ellume Pty Ltd

Completed

Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

Influenza

Australia
Medical University of Vienna

Completed

Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation Therapy

Pneumonia, Ventilator-Associated

Austria
Thrombosis Research Institute
Sanofi

Terminated

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients (ETHIC)

COVID-19

Australia, Belgium, South Africa
Valneva Austria GmbH

Completed

Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients

Pneumonia, Ventilator-Associated

Austria
Savara Inc.

Completed

Pilot Trial of Inhaled Molgramostim in Nontuberculous Mycobacterial (NTM) Infection (OPTIMA)

Mycobacterium Infections, Nontuberculous

Australia, United Kingdom
Codagenix, Inc

Completed

Safety and Immunogenicity of a Live-attenuated Vaccine Against Respiratory Syncytial Virus in Elderly Volunteers

Respiratory Syncytial Virus Infections

Australia

Clinical Trials on Infections, Respiratory Tract in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations